Servier
| Candidate | Targets | Indication | Partner | Our Commercial Rights | Discovery | Preclinical | IND- enabling | Phase I | Phase Ib/IIa |
|---|---|---|---|---|---|---|---|---|---|
| Servier 4 Programs | n.d./n.d. Bispecific | Immuno-Oncology |  | U.S. for 2 bispecifics |
Discovery Phase completed
|
Pre-Clinical Phase not started
|
IND-enabling Phase not started
|
Phase 1 not started
|
Phase 2 not started
|